Avoiding “Pseudo-Reversibility” of CT-CBV Infarct Core Lesions in Acute Stroke Patients After Thrombolytic Therapy | Zendy

Pamela W. Schaefer | Zendy; Kit Mui | Zendy; Shahmir Kamalian | Zendy; Raul G. Nogueira | Zendy; R. Gilberto González | Zendy; Michael H. Lev | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Avoiding “Pseudo-Reversibility” of CT-CBV Infarct Core Lesions in Acute Stroke Patients After Thrombolytic Therapy

Author(s) -

Pamela W. Schaefer,

Kit Mui,

Shahmir Kamalian,

Raul G. Nogueira,

R. Gilberto González,

Michael H. Lev

Publication year - 2009

Publication title -

stroke

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.397

H-Index - 319

eISSN - 1524-4628

pISSN - 0039-2499

DOI - 10.1161/strokeaha.109.547679

Subject(s) - medicine , lesion , stroke (engine) , nuclear medicine , radiology , cardiology , acute stroke , hemodynamics , surgery , tissue plasminogen activator , mechanical engineering , engineering

Rarely, acute ischemic stroke (AIS) patients have pretreatment CT-CBV abnormalities larger than final infarct volumes. We sought to determine: (1) the prevalence of CT-CBV "reversibility" in AIS patients treated with thrombolytic therapy, and (2) whether the presumed tissue salvage of these CT-CBV lesions depends on the CTP software.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research